Valuation: Novartis AG

Market Cap 285B 249B 230B 212B 403B 27,167B 410B 2,750B 1,078B 13,341B 1,068B 1,045B 46,210B P/E 2026 *
21.7x
P/E 2027 * 18.4x
Enterprise Value 317B 277B 255B 236B 449B 30,224B 456B 3,059B 1,199B 14,842B 1,189B 1,163B 51,410B EV / Sales 2026 *
5.57x
EV / Sales 2027 * 5.19x
Free-Float
91.66%
Yield 2026 *
2.83%
Yield 2027 * 2.93%
1 day-1.11%
1 week-2.91%
Current month-1.80%
1 month+5.00%
3 months+1.74%
6 months+9.00%
Current year+13.41%
1 week 124.2
Extreme 124.2
128.7
1 month 117.64
Extreme 117.64
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
05-18Sell -5,200 0.0003%
05-04Sell 6,800 0.0003%
02-17Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%-2.91%+27.42%+44.91% 285B
-0.73%-0.80%+53.03%+165.74% 1,084B
-1.28%-0.97%+66.68%+63.31% 634B
-0.84%-3.97%+31.52%+86.40% 447B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-0.93%-3.57%-27.74%-39.70% 218B
-1.54%-3.14%+22.21%+61.26% 199B
-1.71%+1.83%+18.04%+76.60% 169B
+0.73%-0.27%-5.11%-32.02% 137B
Average -1.35%+2.34%+24.40%+48.42% 379.69B
Weighted average by Cap. -1.26%+2.42%+36.99%+79.32%

Financials

2026 *2027 *
Net sales 56.87B 49.75B 45.87B 42.45B 80.56B 5,428B 81.91B 549B 215B 2,665B 213B 209B 9,233B 60.31B 52.76B 48.65B 45.02B 85.44B 5,757B 86.87B 583B 228B 2,827B 226B 222B 9,792B
Net income 14.1B 12.34B 11.38B 10.53B 19.98B 1,346B 20.32B 136B 53.41B 661B 52.95B 51.8B 2,290B 15.65B 13.69B 12.62B 11.68B 22.17B 1,494B 22.54B 151B 59.26B 733B 58.74B 57.47B 2,541B
Net Debt 32.03B 28.02B 25.84B 23.9B 45.37B 3,057B 46.13B 309B 121B 1,501B 120B 118B 5,200B 28.54B 24.96B 23.02B 21.3B 40.43B 2,724B 41.1B 276B 108B 1,338B 107B 105B 4,633B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
09/07/26 CHF 124.30 -1.27% 2,233,204
08/07/26 CHF 125.90 -0.71% 2,243,169
07/07/26 CHF 126.80 +1.36% 2,306,045
06/07/26 CHF 125.10 -2.20% 2,283,429
03/07/26 CHF 127.92 -0.08% 1,776,406
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.48USD
Average target price
153.92USD
Spread / Average Target
-1.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock